LaminarPace transforms vaccines, drugs and biologics from fragile, difficult-to-transport liquids into robust dry powders, transportable anywhere in the world with no need for costly cold storage or temperature-controlled equipment. And because substances are dried at room temperature, the active ingredient stays active.

Per Gerde, the CSO of Ziccum and Associate Professor of inhalation toxicology at the Division of Physiology, Institute of Environmental Medicine at Karolinska Institutet, will deliver a presentation on LaminarPace to an industry conference in Copenhagen. To register, visit here.